BACKGROUND: The ongoing Ebola outbreak in West Africa has resulted in 28 646 suspected, probable, and confirmed Ebola virus infections. Nevertheless, malaria remains a large public health burden in the region affected by the outbreak. A joint Centers for Disease Control and Prevention/National Institutes of Health diagnostic laboratory was established in Monrovia, Liberia, in August 2014, to provide laboratory diagnostics for Ebola virus. METHODS: All blood samples from suspected Ebola virus-infected patients admitted to the Médecins Sans Frontières ELWA3 Ebola treatment unit in Monrovia were tested by quantitative real-time polymerase chain reaction for the presence of Ebola virus and Plasmodium species RNA. Clinical outcome in laboratory-confirmed Ebola virus-infected patients was analyzed as a function of age, sex, Ebola viremia, and Plasmodium species parasitemia. RESULTS: The case fatality rate of 1182 patients with laboratory-confirmed Ebola virus infections was 52%. The probability of surviving decreased with increasing age and decreased with increasing Ebola viral load. Ebola virus-infected patients were 20% more likely to survive when Plasmodium species parasitemia was detected, even after controlling for Ebola viral load and age; those with the highest levels of parasitemia had a survival rate of 83%. This effect was independent of treatment with antimalarials, as this was provided to all patients. Moreover, treatment with antimalarials did not affect survival in the Ebola virus mouse model. CONCLUSIONS: Plasmodium species parasitemia is associated with an increase in the probability of surviving Ebola virus infection. More research is needed to understand the molecular mechanism underlying this remarkable phenomenon and translate it into treatment options for Ebola virus infection. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: The ongoing Ebola outbreak in West Africa has resulted in 28 646 suspected, probable, and confirmed Ebola virus infections. Nevertheless, malaria remains a large public health burden in the region affected by the outbreak. A joint Centers for Disease Control and Prevention/National Institutes of Health diagnostic laboratory was established in Monrovia, Liberia, in August 2014, to provide laboratory diagnostics for Ebola virus. METHODS: All blood samples from suspected Ebola virus-infectedpatients admitted to the Médecins Sans Frontières ELWA3 Ebola treatment unit in Monrovia were tested by quantitative real-time polymerase chain reaction for the presence of Ebola virus and Plasmodium species RNA. Clinical outcome in laboratory-confirmed Ebola virus-infectedpatients was analyzed as a function of age, sex, Ebola viremia, and Plasmodium species parasitemia. RESULTS: The case fatality rate of 1182 patients with laboratory-confirmed Ebola virus infections was 52%. The probability of surviving decreased with increasing age and decreased with increasing Ebola viral load. Ebola virus-infectedpatients were 20% more likely to survive when Plasmodium species parasitemia was detected, even after controlling for Ebola viral load and age; those with the highest levels of parasitemia had a survival rate of 83%. This effect was independent of treatment with antimalarials, as this was provided to all patients. Moreover, treatment with antimalarials did not affect survival in the Ebola virusmouse model. CONCLUSIONS: Plasmodium species parasitemia is associated with an increase in the probability of surviving Ebola virus infection. More research is needed to understand the molecular mechanism underlying this remarkable phenomenon and translate it into treatment options for Ebola virus infection. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry Journal: N Engl J Med Date: 2014-10-29 Impact factor: 91.245
Authors: Etienne Gignoux; Andrew S Azman; Martin de Smet; Philippe Azuma; Moses Massaquoi; Dorian Job; Amanda Tiffany; Roberta Petrucci; Esther Sterk; Julien Potet; Motoi Suzuki; Andreas Kurth; Angela Cannas; Anne Bocquin; Thomas Strecker; Christopher Logue; Thomas Pottage; Constanze Yue; Jean-Clement Cabrol; Micaela Serafini; Iza Ciglenecki Journal: N Engl J Med Date: 2016-01-07 Impact factor: 91.245
Authors: Andrea Marzi; Shelly J Robertson; Elaine Haddock; Friederike Feldmann; Patrick W Hanley; Dana P Scott; James E Strong; Gary Kobinger; Sonja M Best; Heinz Feldmann Journal: Science Date: 2015-08-06 Impact factor: 47.728
Authors: Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol Journal: J Virol Date: 2004-04 Impact factor: 5.103
Authors: Mateusz M Plucinski; Timothée Guilavogui; Sidibe Sidikiba; Nouman Diakité; Souleymane Diakité; Mohamed Dioubaté; Ibrahima Bah; Ian Hennessee; Jessica K Butts; Eric S Halsey; Peter D McElroy; S Patrick Kachur; Jamila Aboulhab; Richard James; Moussa Keita Journal: Lancet Infect Dis Date: 2015-06-23 Impact factor: 25.071
Authors: Kristen L Lokken; Jason P Mooney; Brian P Butler; Mariana N Xavier; Jennifer Y Chau; Nicola Schaltenberg; Ramie H Begum; Werner Müller; Shirley Luckhart; Renée M Tsolis Journal: PLoS Pathog Date: 2014-05-01 Impact factor: 6.823
Authors: Patrick G T Walker; Michael T White; Jamie T Griffin; Alison Reynolds; Neil M Ferguson; Azra C Ghani Journal: Lancet Infect Dis Date: 2015-04-23 Impact factor: 25.071
Authors: J Daniel Kelly; Eugene T Richardson; Michael Drasher; M Bailor Barrie; Sahr Karku; Mohamed Kamara; Katrina Hann; Kerry Dierberg; Allan Hubbard; Christina P Lindan; Paul E Farmer; George W Rutherford; Sheri D Weiser Journal: Am J Trop Med Hyg Date: 2018-03-15 Impact factor: 2.345
Authors: Kai J Rogers; Olena Shtanko; Rahul Vijay; Laura N Mallinger; Chester J Joyner; Mary R Galinski; Noah S Butler; Wendy Maury Journal: Cell Rep Date: 2020-03-24 Impact factor: 9.423
Authors: Stephen B Kennedy; Fatorma Bolay; Mark Kieh; Greg Grandits; Moses Badio; Ripley Ballou; Risa Eckes; Mark Feinberg; Dean Follmann; Birgit Grund; Swati Gupta; Lisa Hensley; Elizabeth Higgs; Krisztina Janosko; Melvin Johnson; Francis Kateh; James Logue; Jonathan Marchand; Thomas Monath; Martha Nason; Tolbert Nyenswah; François Roman; Eric Stavale; Julian Wolfson; James D Neaton; H Clifford Lane Journal: N Engl J Med Date: 2017-10-12 Impact factor: 91.245
Authors: Hannah M Edwards; Helen Counihan; Craig Bonnington; Jane Achan; Prudence Hamade; James K Tibenderana Journal: PLoS One Date: 2021-05-24 Impact factor: 3.240
Authors: Michael A Smit; Ian C Michelow; Justin Glavis-Bloom; Vanessa Wolfman; Adam C Levine Journal: Clin Infect Dis Date: 2016-10-25 Impact factor: 9.079
Authors: Jeremy N Burrows; Stephan Duparc; Winston E Gutteridge; Rob Hooft van Huijsduijnen; Wiweka Kaszubska; Fiona Macintyre; Sébastien Mazzuri; Jörg J Möhrle; Timothy N C Wells Journal: Malar J Date: 2017-01-13 Impact factor: 2.979